Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04952480 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Dose-escalated Adaptive Radiotherapy of Thoracic Disease for Small Cell Lung Cancer

Study acronym: DARTS
StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 12, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. 2 versions Re-verified since Jan 29, 2024, no change to tracked fieldsv5-v6
  2. Start date changed from estimate of Apr 25, 2022 to Jun 13, 2022v4
  3. Trial status: Not Yet Recruiting to Recruitingv3 Show 5 more changesShow less
    • Start date: Dec 1, 2021 to Apr 25, 2022
    • Enrollment target: 28 to 31
    • Study sites: 0 to 1
    • Primary and study completion dates: Jun 1, 2025 to Nov 1, 2025
    • Eligibility criteria expanded, about 49 words
  4. Re-verified, no change to tracked fieldsv2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to find out what effects of using adaptive radiotherapy to deliver chest radiation has on the ability to control lung cancer and side effects.
Trial Details
NCT Number NCT04952480
Lead Sponsor AHS Cancer Control Alberta
Conditions
(from sponsor)		 Small Cell Lung Cancer
Related terms Small Cell Lung Carcinoma
Enrollment 31 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov